Results 271 to 280 of about 28,111,627 (303)

From SARS to COVID‐19: Crisis Governance and Institutional Learning in Taiwan

Journal of Contingencies and Crisis Management, Volume 34, Issue 3, September 2026.
ABSTRACT This article examines how Taiwan's crisis governance evolved from the SARS outbreak of 2003 to the COVID‐19 pandemic of 2020–2023, tracing the institutional learning mechanisms that transformed a widely criticized governance failure into an internationally recognized model of pandemic preparedness. Employing a diachronic comparative case study
Ching‐Cheng Lin
wiley   +1 more source

Validation of a Pseudovirus Neutralization Assay for Severe Acute Respiratory Syndrome Coronavirus 2 Omicron JN.1 and LP.8.1 Subvariant Lineage Strains with Homologous and Heterologous Matched Sera in Clinically Relevant Samples. [PDF]

Microorganisms
Cai Z, Kalkeri R, Haner B, Wang M, Skonieczny P, Osman B, Dent D, Silva D, Auerbach K, Faust E, Feng SL, Cai MR, Zhu M, Cloney-Clark S, Plested JS.   +14 more
europepmc   +1 more source

Prevalence of and risk factors for post-coronavirus disease 2019 symptoms after severe acute respiratory syndrome coronavirus 2 infection in healthcare workers: A multicenter cross-sectional study in China. [PDF]

J Int Med Res
Song JB, Xu JT, Shao LC, Luo H, Chen JH, Lv L, Ye XN, Wu XD.   +7 more
europepmc   +1 more source

Incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in North Carolina from December 2020 - February 2022. [PDF]

PLoS One
Miller EM, Boyce RM, Kipp AM, Newby LK, Woods CW, Cassidy CA, Gunderson AK, Lea CS, Neighbors CE, Shook-Sa BE, Sloane R, Starling AP, Wambui D, Wixted D, Fleischauer A, Aiello AE.   +15 more
europepmc   +1 more source

Differentiating Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Responses Between Infection and Vaccination: Challenges for Epidemiological Research. [PDF]

J Infect Dis
Nayagam SN, Coote W, Carroll MTC, Toh ZQ, Licciardi PV, Abramson MJ, Walker-Bone K, Lane TJ.   +7 more
europepmc   +1 more source

Correction to: Hybrid B- and T-Cell Immunity Associates With Protection Against Breakthrough Infection After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Avon Longitudinal Study of Parents and Children (ALSPAC) Participants. [PDF]

J Infect Dis
europepmc   +1 more source

Human Source Severe Acute Respiratory Syndrome Coronavirus 2 Aerosol Transmission to Remote Sentinel Hamsters. [PDF]

Open Forum Infect Dis
Roy CJ, Barer MR, Ueckermann V, Beddingfield B, Cordier D, Fourie B, Vincent R, Dibobo S, VanReenen T, Jensen P, De Kock O, De Kock E, Nardell E.   +12 more
europepmc   +1 more source

Understanding neurodegeneration and regeneration in the CNS: New concepts, clinical investigations, and an unsung hero of neuroscience

Neuroprotection, Volume 4, Issue 3, Page 191-194, September 2026.
Piotr Walczak, Shen Li, Xunming Ji, Johannes Boltze   +3 more
wiley   +1 more source

Comparable immune escape capacity for NB.1 with that of JN.1 variant and survey of infection with severe acute respiratory syndrome coronavirus 2 variants among Chinese <i>Felis silvestris catus</i>. [PDF]

Front Immunol
Yuan Y, Geng Y, Zhu Q, Sun B, Xu J, Mao X, Zhang X, Tian W, Zhao J, Zheng P, Gao L.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The Origins of Severe Acute Respiratory Syndrome-Coronavirus-2

Seminars in Respiratory and Critical Care Medicine, 2023
AbstractAn outbreak of severe pneumonia of unknown cause was identified in Wuhan, China in December 2019: the causative agent was a novel betacoronavirus, severe acute respiratory syndrome-cotonavirus-2 (SARS-CoV-2), a virus that joins a list of coronaviruses causing severe (e.g., SARS and Middle East respiratory syndrome) or milder (e.g., 229E, OC43 ...
openaire   +2 more sources